The stock value of Regulus Therapeutics Inc. (NASDAQ: RGLS) has increased significantly, rising by 116.67% to $2.99 per share during the current trading session. This
On January 20, Regulus Therapeutics Inc. (RGLS) announced the successful completion of the pre-IND meeting for RGLS8429 with the FDA. Consequently, the stock advanced further
On December 10, the American stock indexes finished trading in different directions. The S&P 500 Index dropped 0.13% to 3668 points, the Dow Jones lost
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.